CMG Pharmaceutical Co., Ltd. Logo

CMG Pharmaceutical Co., Ltd.

Develops and manufactures prescription drugs, specializing in Oral Thin Film (OTF) technology.

058820 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
서울특별시 강남구 학동로 170 베터라이프빌딩 3층(논현동), 강남구
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

CMG Pharmaceutical Co., Ltd. is a pharmaceutical company engaged in the research, development, manufacturing, and sale of medications. As the sole pharmaceutical affiliate of CHA Health Systems, the company focuses on developing improved drugs and new formulations. A key area of its technological specialization is Oral Thin Film (OTF) pharmaceuticals, exemplified by its Tadalafil OTF product. The company's portfolio also includes prescription drugs in various forms such as tablets and capsules. CMG Pharmaceutical actively maintains a drug development pipeline and conducts clinical trials to address various therapeutic needs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-11 00:00
Share Issue/Capital Change
전환가액의조정
Korean 17.5 KB
2025-08-13 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.6 MB
2025-06-25 00:00
Share Issue/Capital Change
전환청구권행사
Korean 10.3 KB
2025-06-09 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 80.4 KB
2025-05-14 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.4 MB
2025-04-30 00:00
Regulatory News Service
소속부변경
Korean 3.6 KB
2025-04-18 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 66.3 KB
2025-04-18 00:00
Share Issue/Capital Change
전환청구권행사
Korean 9.5 KB
2025-04-16 00:00
Regulatory News Service
투자판단관련주요경영사항 (메조피(Mezofy) 미국 식품의약국(FDA) 품목허가 획득)
Korean 7.3 KB
2025-04-15 00:00
Regulatory News Service
[기재정정]신규시설투자등
Korean 15.7 KB
2025-03-28 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 17.2 KB
2025-03-20 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 659.1 KB
2025-03-19 00:00
Audit Report / Information
감사보고서제출
Korean 25.0 KB
2025-03-12 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 6.5 KB
2025-03-12 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 181.1 KB

Automate Your Workflow. Get a real-time feed of all CMG Pharmaceutical Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for CMG Pharmaceutical Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America 950130
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI

Talk to a Data Expert

Have a question? We'll get back to you promptly.